- UroToday Home
- Recent Abstracts
- Urologic Oncology
Prostate Cancer
Vitamin D(3) supplementation, low-risk prostate cancer, and health disparities - Abstract
January 8, 2013
Does quality of life of prostate cancer patients differ by stage and treatment? - Abstract
January 8, 2013
Strategies for optimizing the clinical impact of immunotherapeutic agents such as sipuleucel-T in prostate cancer - Abstract
January 8, 2013
Treatment patterns for prostate cancer: Comparison of medicare claims data to medical record review - Abstract
January 8, 2013
The role of the elastography in the diagnosis of prostate cancer: A retrospective study on 460 patients - Abstract
January 7, 2013
Primary treatments for clinically localised prostate cancer: a comprehensive lifetime cost-utility analysis - Abstract
January 7, 2013
How prostate cancer therapies compare by cost and effectiveness
January 7, 2013
Maximal androgen blockade little influences bone mineral density in prostate cancer patients - Abstract
January 7, 2013
Cancer identified incidentally in the prostate following radical cystoprostatectomy: An Australian study - Abstract
January 7, 2013
The role of serum testosterone to prostate-specific antigen ratio as a predictor of prostate cancer risk - Abstract
January 7, 2013
Progress in prostate cancer imaging - Abstract
January 7, 2013
Stereotactic body radiation therapy for prostate cancer: Is the technology ready to be the standard of care? - Abstract
January 7, 2013
Updated tool now available to predict prostate cancer spread
January 5, 2013
Novel strategies to test biological hypotheses in early drug development for advanced prostate cancer - Abstract
January 4, 2013
Managed care and the diffusion of intensity-modulated radiotherapy for prostate cancer - Abstract
January 4, 2013
Bone scan is of doubtful value as a first staging test in the primary presentation of prostate cancer - Abstract
January 4, 2013